These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10954661)

  • 1. Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study.
    Timonen K; Kariniemi AL; Niemi KM; Teppo AM; Tenhunen R; Kauppinen R
    J Am Acad Dermatol; 2000 Sep; 43(3):489-97. PubMed ID: 10954661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
    Lim HW
    Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypically localized persistent skin changes in erythropoietic protoporphyria (EPP)--histologic and electron microscopic findings (author's transl)].
    Meigel W; Schaeg G; Goerz G
    Z Hautkr; 1981 Apr; 56(8):489-97. PubMed ID: 7245820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocytoclastic vasculitis masking chronic vascular changes in previously undiagnosed erythropoietic protoporphyria.
    Thom G; Lam M; Lucas M; Rossi E
    J Cutan Pathol; 2013 Nov; 40(11):966-71. PubMed ID: 24102632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.
    Preisz K; Sárdy M; Horváth A; Kárpáti S
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):74-9. PubMed ID: 15649195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
    Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
    J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.
    Goerz G; Bunselmeyer S; Bolsen K; Schürer NY
    Br J Dermatol; 1996 May; 134(5):880-5. PubMed ID: 8736329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immunofluorescence analysis.
    Krajnc I; Vizjak A; Hvala A; Jurcić V; Rozman B
    Wien Klin Wochenschr; 1998 Oct; 110(18):651-4. PubMed ID: 9816639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Porphyria in dermatology].
    Nonaka S; Takamiyagi A; Maruno M
    Nihon Rinsho; 1995 Jun; 53(6):1449-55. PubMed ID: 7616662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietic protoporphyria. An overview with emphasis on the liver.
    Meerman L
    Scand J Gastroenterol Suppl; 2000; (232):79-85. PubMed ID: 11232498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
    Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
    Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria.
    Libbrecht L; Meerman L; Kuipers F; Roskams T; Desmet V; Jansen P
    J Pathol; 2003 Feb; 199(2):191-200. PubMed ID: 12533832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.
    Eichbaum QG; Dzik WH; Chung RT; Szczepiorkowski ZM
    Transfusion; 2005 Feb; 45(2):208-13. PubMed ID: 15660829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
    Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
    Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythropoietic protoporphyria].
    Miura T
    Nihon Rinsho; 1995 Jun; 53(6):1438-42. PubMed ID: 7616660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of IgA and TG3 on healthy skin of coeliac patients.
    Cannistraci C; Lesnoni La Parola I; Cardinali G; Bolasco G; Aspite N; Stigliano V; Picardo M
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):509-14. PubMed ID: 17373979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular anomalies in lipoid proteinosis (hyalinosis cutis et mucosae): basement membrane components and ultrastructure.
    Mirancea N; Hausser I; Beck R; Metze D; Fusenig NE; Breitkreutz D
    J Dermatol Sci; 2006 Jun; 42(3):231-9. PubMed ID: 16497486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic pigmented spots on the extrapretibial region: immunohistochemical study of type IV collagen in dermal vessel wall.
    Chishiki M; Ohnishi Y; Kawada A; Tajima S; Ishibashi A
    Eur J Dermatol; 1998 Dec; 8(8):560-2. PubMed ID: 9889428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies of amyloid P component and fibronectin in erythropoietic protoporphyria.
    Breathnach SM; Bhogal B; de Beer FC; Melrose SM; Black MM; Pepys MB
    Br J Dermatol; 1983 Mar; 108(3):267-75. PubMed ID: 6338898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.